Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zomedica Pharmaceuticals Corp. (ZOM)

0.1681   -0.003 (-1.7%) 07-10 16:00
Open: 0.171 Pre. Close: 0.171
High: 0.171 Low: 0.166
Volume: 42,112,503 Market Cap: 88M
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.17 - 0.171 0.171 - 0.172
Low: 0.167 - 0.169 0.169 - 0.17
Close: 0.168 - 0.17 0.17 - 0.172

Technical analysis

as of: 2020-07-10 4:33:46 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.27     One year: 0.32
Support: Support1: 0.16    Support2: 0.13
Resistance: Resistance1: 0.23    Resistance2: 0.28
Pivot: 0.20
Moving Average: MA(5): 0.17     MA(20): 0.20
MA(100): 0.20     MA(250): 0.27
MACD: MACD(12,26): -0.01     Signal(9):
Stochastic oscillator: %K(14,3): 14.19     %D(3): 15.01
RSI: RSI(14): 42.23
52-week: High: 0.50  Low: 0.11  Change(%): -32.8
Average Vol(K): 3-Month: 6033090  10-Days: 11382259

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ZOM has closed above bottom band by 22.3%. Bollinger Bands are 1.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 10 Jul 2020
Zomedica Pharmaceuticals Corp. (ZOM) Chart Is Flashing Mixed Signals - The News Heater

Wed, 08 Jul 2020
Technical Traders Must Watch Zomedica Pharmaceuticals Corp. (ZOM) - The News Heater

Tue, 07 Jul 2020
Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering - GlobeNewswire

Tue, 07 Jul 2020
Here is why Zomedica Pharmaceuticals Corp. (ZOM) stock volatility recorded over the last month was 13.31% - The InvestChronicle

Wed, 01 Jul 2020
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering - GlobeNewswire

Wed, 01 Jul 2020
Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Drug ManufacturersSpecialty & Generic
Shares Out. (M) 292
Shares Float (M) 138
% Held by Insiders 38.45
% Held by Institutions 9.67
Shares Short (K) 7,150
Shares Short P. Month (K) 10,420

Stock Financials

EPS -0.095
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.080
Profit Margin
Operating Margin
Return on Assets (ttm) -119.3
Return on Equity (ttm) -29421.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.035
Qtrly Earnings Growth
Operating Cash Flow (M) -15
Levered Free Cash Flow (M) -12

Stock Valuations

PE Ratio -1.77
PEG Ratio
Price to Book value -2.10
Price to Sales
Price to Cash Flow -3.22

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.